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Background: Home-use HIV tests have the potential to increase testing and may be used by sex partners to
inform sexual decision-making. To our knowledge, this is the first report of an individual diagnosed with HIV using
a home-use test with a sex partner.
Case presentation: We are conducting a randomized controlled trial of home self-testing for HIV using the
OraQuick ADVANCEW HIV-1/2 Antibody Test on oral fluids. In 2011, a 27-year-old, homeless, Latino man who has
sex with men not enrolled in the trial (the case) reported receiving a reactive result from a diverted study kit.
When interviewed by study staff, the case reported that, 11 months prior, he had unprotected anal sex with a trial
subject without discussing HIV status. Afterwards, the subject asked the case if he would like to test, performed
the test, and disclosed the reactive result. The case reported altering his behavior to decrease the risk of HIV
transmission to subsequent partners and sought care two months later.
Conclusions: This case demonstrates that home-use HIV tests will be used by sex partners to learn and disclose HIV
status and inform sexual decision-making. It also highlights concerns regarding the absence of counseling and the
potential for delayed entry into HIV care. Additional research must be done to determine under what circumstances
home-use tests can be used to increase awareness of HIV status, how they impact linkage to care among persons
newly diagnosed with HIV, and whether they can be safely used to increase the accuracy of serosorting.
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HIV testing is not only the entry point into care for
HIV-infected individuals but also an effective prevention
intervention because most newly-diagnosed individuals
will alter their behavior to decrease transmission to
others [1] and antiretroviral therapy can reduce infec-
tiousness [2].
In 1996, the U.S. Food and Drug Administration
(FDA) approved the Home Access HIV-1 Test System
(Home Access Health Corporation; Hoffman Estates,
IL), a home collection kit for HIV antibody testing. With
home collection, testers send self-collected dried blood
spots to a laboratory and learn their test results by
phone. In the first year it was available, 174,316 kits were
sold and 0.9% persons were positive, 49% of whom* Correspondence: dkatz7@u.washington.edu
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reproduction in any medium, provided the orhad never tested before [3]. Few have used these kits,
however, in part due to concerns about accuracy and
cost [3-5].
Home-use tests, through which testers use a rapid
HIV test on self-collected oral fluids or blood to learn
their HIV status at home, have been posited as an alter-
native method to increase HIV testing [6-8] and thereby
decrease the time HIV-infected individuals are unaware
of their status and potential for transmission. However,
there are concerns about the potential for misinter-
pretation of test results, greater number of false-negative
test results during the relatively long window period of
currently available rapid tests, reduced access to risk-
reduction counseling, decreased screening for sexually
transmitted infections (STIs), missed opportunities to
link HIV-infected persons into care or to perform part-
ner services, and reduced accuracy of HIV surveillance
[7-10]. When home-use tests are available over-the-
counter, they may also be used by sex partners to inform
sexual decision-making [11].. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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counter home-use HIV test, the OraQuickW In-Home
HIV Test (OraSure Technologies, Inc., Bethlehem, PA).
In premarketing studies of untrained users in uncon-
trolled settings, the test was 93.0% sensitive, 99.98% spe-
cific, and had a window period of 3 months [7]. No
industry-sponsored studies were planned to address
whether at-risk individuals will be more likely to test or
to test more often if home-use tests are available; con-
cerns regarding reductions in counseling, linkage to care,
and accuracy of surveillance; or home testing by sex
partners [7].
The iTest Study is an ongoing, NIH-funded, rando-
mized controlled trial to evaluate the impact of access to
home-use tests on HIV testing frequency. HIV-negative
men who have sex with men (MSM) are randomized to
home self-testing using the OraQuick ADVANCEW
Rapid HIV-1/2 Antibody Test (which uses the same
technology as the approved home-use test) on oral fluids
or to standard HIV testing for 15 months (Clinicaltrials.
gov Identifier NCT01161446). Participants randomized
to home self-testing are trained to use the test at enroll-
ment and receive one test kit at a time for use on them-
selves only. Study test kits include the test and study-
specific instructions, counseling materials, and local
resources and are provided at no cost to participants.
We report the diversion of a study test kit to test a
trial subject’s sex partner, whose rapid HIV test on oral
fluids was reactive. To our knowledge, this is the first
report of an individual diagnosed with HIV using a
home-use test with a sex partner.
Case presentation
In 2011, a 27-year-old, homeless, gay-identified Latino
MSM not enrolled in the trial (the case) was seen at
the Public Heath – Seattle & King County (PHSKC)
STD Clinic and reported receiving a reactive result from
a diverted study kit. This case study received ethical
approval from the University of Washington Institu-
tional Review Board, and written informed consent was
obtained from the case for a semi-structured interview
about his experience testing with a sex partner and sub-
sequent entry into care.
The case reported that, 11 months prior to this inter-
view, he had unprotected anal sex and used metham-
phetamine with a trial subject without discussing HIV
status. Afterwards, the trial subject asked the case if he
wanted to use a study test kit. The case last tested
13 months earlier. The trial subject collected the case’s
oral fluid sample, performed the test, and disclosed the
reactive result. The case thought it was an acceptable way
to learn his HIV status. The case and trial subject did not
engage in further sexual activity. Neither confirmatory
testing nor post-exposure prophylaxis was discussed.The case did not seek confirmatory testing immedi-
ately. He assumed the results were definitive and did not
want antiretroviral therapy. He reported being subse-
quently more likely to disclose his HIV status and use
condoms with sex partners. Two months later, he sought
confirmatory testing at the PHSKC STD Clinic. He
initiated HIV care two months after confirmatory testing.
Six months after the home test, his CD4+ T-cell count
was 396 cells/mL, and his HIV RNA level was 15,080
copies/mL. One year after the home test, he was engaged
in HIV care [12] but not receiving antiretroviral therapy.
This case highlights potential benefits and risks of
home-use HIV tests. First, home-use tests have the poten-
tial to increase testing due to convenience, anonymity,
and reduced time needed to test [6-8]. Furthermore, the
test result obtained by the trial subject was accurate, the
newly-diagnosed case felt comfortable receiving his result
from a partner in a nonmedical setting, and the case
altered his behavior to reduce ongoing HIV transmission
despite the absence of post-test counseling. On the other
hand, although the case received the correct preliminary
result, he was unaware that he needed confirmatory test-
ing and delayed seeking care. The absence of post-test
counseling also meant that the trial subject, whose identity
remains unknown to us, was unaware of the availability of
and recommendation for post-exposure prophylaxis.
Although in this case the partners had already engaged
in unprotected sex, partners may choose to test together
to inform sexual decision-making. Many MSM serosort
(i.e. choose to have sex only with partners of concordant
HIV status, to use condoms only with discordant
partners, or to have HIV-negative partners be the inser-
tive partner in discordant partnerships) based on what
partners disclose directly or indirectly [13]. If MSM trust
the results of home-use tests and are therefore more
likely to serosort, the ability for sex partners to test at
home could increase unprotected sex and allow for trans-
mission of other STIs. OraQuick’s relatively long window
period [14] could also increase false-negative results dur-
ing primary infection and lead to unprotected sex when
individuals are most infectious. However, the results of
home-use tests may be more accurate than self-reported
HIV status and may therefore decrease unprotected sex
between serodiscordant partners [15]. Another concern is
that the availability of home-use tests may result in
coerced testing or intimate partner violence, particularly
if partnerships are newly identified as serodiscordant.
This case report relied on an interview with the case
and therefore may be limited by recall error and social
desirability bias.
Conclusions
This case demonstrates that home-use tests can be used
to successfully identify HIV infection and that they will
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also highlights concerns about the absence of post-test
counseling and the potential for delayed linkage to care
among those who receive reactive home-use tests. The
U.S. National HIV/AIDS Strategy emphasizes immediate
linkage to care [16] because delaying care can adversely
impact the HIV-infected individual’s health [17] and
ongoing transmission [2]. Additional research must be
done to determine under what circumstances home-use
tests can be used to increase awareness of HIV status,
how they impact linkage to care among persons newly
diagnosed with HIV, and whether home-use tests can be
safely used to increase the accuracy of serosorting.
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